Peptide Decoding
New?New to peptides?Start here →
Decoding

Sigumir_Dosage, benefits & legal status

Published July 22, 2026 · Updated August 14, 2026

A bioregulator for bone, joint, and cartilage health, with thin evidence.

Joints & cartilageBioregulator peptideResearch only
Common vial size10 mg
DoseVaries (course-based)
FrequencyCourses
RouteUnder the skin, or by mouth
StatusResearch only
CycledCourses of 10 to 20 days, repeated two or three times a year

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

01

What is Sigumir?

Plain language first. The technical label stays, but it never stands alone.

Overview

It is marketed for bone, joint, and cartilage health, but there is very little real human research behind it.

The technical version

Sigumir is a peptide 'bioregulator' from the Russian Khavinson family, drawn from cartilage.

What it's used for

A bioregulator aimed at bone, joint, and cartilage health, taken in short courses.

02

How does Sigumir work?

What it does in the body, and where.

Sigumir, like Cerluten, is a crude tissue extract rather than a defined peptide, drawn from cartilage.

  1. 01
    It is a cartilage extract
    Marketed for bone and joint support.
  2. 02
    No citable human evidence, and no defined sequence
    Composition is uncharacterised and batch-dependent.
03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Bone, joint, and cartilage healthResearch only

The published record

Research index

3

Records indexed for Sigumir

3 in humans, 2 of them original studies.

Browse the records

In animalsPro
In the labPro
ReviewsPro
Senior author sharePro

Counted from Europe PMC indexing, not read by a person. Human means indexed under humans, which includes reviews and work on human cells. Original studies exclude reviews and lab work on human cells.Last updated 12 September 2026.

Sigumir vial rendering
Compound field notes

At a glance

Four things to know about Sigumir

01

Evidence

Research only

02

Category

Healing and recovery

03

Common vial

10 mg

04

Half-life

Nothing published

04

How much, and do you cycle it?

The range, and whether you take breaks.

Varies (course-based), courses. Courses of 10 to 20 days, repeated two or three times a yearCommunity practice

The course structure is how the Khavinson protocols specify these and how they are sold. No trial has compared course dosing against continuous use, or established how long the gap between courses should be.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing publishedNo figure

No half-life has ever been published for any of the Russian bioregulator peptides, in people or in animals. The research behind them, mostly from one group in St Petersburg, measures effects on tissue, gene activity and lifespan. None of it measures how long the peptide stays in the body.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced range: Varies (course-based)No range

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

Your draw

0 / 100 units
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized Sigumir keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • Pregnancy or breastfeeding
  • Any prescription medicine you take regularly, without checking for interactions first
  • Anyone who wants established safety data, because none exists for this compound in humans

Stop and get help

These are emergencies. Seek care.
  • Spreading hives, swelling of the face or throat, or trouble breathing, which can happen with any injection and is a medical emergency
  • Redness, heat, or pus at the injection site, which can signal infection
  • Any severe or unexpected symptom
  • Anything unusual, since there is no known safety profile to compare it against

Common effects

Expected, and usually mild.
  • Little human evidence.
  • Redness, soreness, or a small bump at the injection site
  • Beyond the above, unknown. There is no reliable human data on what this compound commonly causes

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Sigumir approved?

And where the numbers on this page come from.

No. Sigumir is not approved for any use, anywhere. It is sold labelled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin, or by mouth
  • Checked
    July 2026

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

You can compare this against the whole library, or read how to check a seller.


Guides for this compound

Sources

  • Khavinson et al., Peptide Regulation of Gene Expression: A Systematic Review (Molecules 26:7053)(2021)
    This is an extract of cartilage, not a single defined molecule, and this review is the originating group's own account of that class. It calls them cytomedines, peptide fractions isolated from animal organs, and states that their action is specific to the cell populations they were taken from. That claim is the whole reason a cartilage extract is sold for joints and cartilage, so it is worth knowing where it comes from and what supports it. The review is written by Khavinson and colleagues at the Saint Petersburg institute where these products originated, so it is the source group making its own case, and the evidence behind it is cell culture, animal work and molecular modelling rather than trials in people.
  • FDA, bulk drug substances nominated for use in compounding under section 503A, updated 14 May 2026(2026)
    A cartilage extract sold in the United States has no regulatory standing here at all. Two peptides from this same Russian family, Epitalon and Semax, went before FDA's Pharmacy Compounding Advisory Committee in July 2026. The products sold alongside them, including this one, appear in none of the three categories on this list, which has been open to nominations since 2013 and drew over two thousand submissions.

Last reviewed 22 July 2026

Beyond these, 3 records are indexed. Browse the records